Product Wiki · Recalls · Health Canada — Medical Devices

ADVIA CENTAUR ENHANCED ESTRADIOL (2016-01-14) — recall 54880

Health Canada — Medical Devices · Canada · 2016-01-25 · Type I

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
54880
Date of alert
2016-01-25
Country / jurisdiction
Canada
Risk level
Type I
Risk type
recall
Product category
Health products
Product type
Medical devices
Notice status
Archived by the issuing authority — kept for reference
Reported risk: Siemens Healthcare Diagnostics is conducting a correction for all lots of ADVIA Centaur Enhanced Estradiol, Dimension Vista LOCI Estradiol, IMMULITE/IMMULITE 1000 Estradiol and IMMULITE 2000 Estradiol. Siemens has confirmed the drug fulvestrant (FASLODEX) may cause falsely elevated estradiol results in the assays listed.
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/advia-centaur-enhanced-estradi

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

Related

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.